Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Ito

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Hepato-Gastroenterology|March 13, 2003
Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobesYuichiro Ito, Hikaru Fujioka, Sumihiro Matsuzaki, et al.
BMC Cancer|June 20, 2023
Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillanceHiroyuki Nishiyama, Yu Tanaka, Masahiro Hamada, et al.
Japanese Journal of Clinical Oncology|May 18, 2025
Effectiveness and safety of pembrolizumab for the treatment of Japanese patients with microsatellite instability-high tumors excluding colorectal cancer: a post-marketing surveillanceDaisuke Aoki, Mai Yamauchi, Makiko Izawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2009
Efficacy and limitation of bone marrow transplantation in the treatment of acute and subacute liver failure in ratsHirotaka Tokai, Yujo Kawashita, Yuichiro Ito, et al.
Advances in Therapy|February 16, 2024
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in JapanTakayuki Hamano, Yusuke Yamaguchi, Kashia Goto, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 14, 2019
Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical TrialsAtsunori Kashiwagi, Marina V Shestakova, Yuichiro Ito, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 28, 2013
A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancerYasuhide Yamada, Naomi Kiyota, Nozomu Fuse, et al.
Hepato-Gastroenterology|May 18, 2004
Successful surgical treatment for metachronous advanced cancers of the gallbladder and the common bile duct--case reportHiroyuki Yuzawa, Yoshito Ikematsu, Yuichiro Ito, et al.
Urologic Oncology|October 16, 2024
Real-world treatment patterns and outcomes of patients with unresectable or metastatic urothelial carcinoma receiving systemic therapy in JapanShotaro Yasuoka, Toshihiko Minegishi, Shingo Kojima, et al.
Asian Journal of Surgery|March 6, 2007
Chronic gastric anisakiasis presenting as pneumoperitoneumYuichiro Ito, Yoshito Ikematsu, Hiroyuki Yuzawa, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Hepato-Gastroenterology|March 13, 2003
Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobesYuichiro Ito, Hikaru Fujioka, Sumihiro Matsuzaki, et al.
BMC Cancer|June 20, 2023
Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillanceHiroyuki Nishiyama, Yu Tanaka, Masahiro Hamada, et al.
Japanese Journal of Clinical Oncology|May 18, 2025
Effectiveness and safety of pembrolizumab for the treatment of Japanese patients with microsatellite instability-high tumors excluding colorectal cancer: a post-marketing surveillanceDaisuke Aoki, Mai Yamauchi, Makiko Izawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2009
Efficacy and limitation of bone marrow transplantation in the treatment of acute and subacute liver failure in ratsHirotaka Tokai, Yujo Kawashita, Yuichiro Ito, et al.
Advances in Therapy|February 16, 2024
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in JapanTakayuki Hamano, Yusuke Yamaguchi, Kashia Goto, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 14, 2019
Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical TrialsAtsunori Kashiwagi, Marina V Shestakova, Yuichiro Ito, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 28, 2013
A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancerYasuhide Yamada, Naomi Kiyota, Nozomu Fuse, et al.
Hepato-Gastroenterology|May 18, 2004
Successful surgical treatment for metachronous advanced cancers of the gallbladder and the common bile duct--case reportHiroyuki Yuzawa, Yoshito Ikematsu, Yuichiro Ito, et al.
Urologic Oncology|October 16, 2024
Real-world treatment patterns and outcomes of patients with unresectable or metastatic urothelial carcinoma receiving systemic therapy in JapanShotaro Yasuoka, Toshihiko Minegishi, Shingo Kojima, et al.
Asian Journal of Surgery|March 6, 2007
Chronic gastric anisakiasis presenting as pneumoperitoneumYuichiro Ito, Yoshito Ikematsu, Hiroyuki Yuzawa, et al.
Pageof 4